Continuous Insulin Infusion (CSII) or modern type of Multiple Daily Injections (MDI) in diabetic children and adolescents a critical review on a controversial issue

Pediatric Endocrinology Reviews

Volumn 5, Issue 2, 2007, Pages 666-678

  Ludvigsson, Johnny ^a   Samuelsson, Ulf ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Adolescents; Children; CSII; Diabetes complications; Insulin pump; MDI; Metabolic control; Quality of life; Type 1 diabetes

Indexed keywords

INSULIN; INSULIN GLARGINE; INSULIN ZINC SUSPENSION;

BODY MASS; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; HEALTH EDUCATION; HUMAN; HYPOGLYCEMIA; INFECTION; INSULIN PUMP; METABOLIC REGULATION; QUALITY OF LIFE; REVIEW; SELF CONTROL; TREATMENT DURATION; WEIGHT GAIN;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INJECTIONS; INSULIN; INSULIN INFUSION SYSTEMS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 37549057941     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Diabetes Control and Complications Trial research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-983
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS33). Lancet 1998;352:837-857
3. Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J. Declining incidence of nephropathy in insulin-dependent diabetes. N Engl J Med 1994;330:15-18
4. Nordwall M, Bojestig M, Arnqvist HJ, Ludvigsson J. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of type 1 diabetes - the Linköping Diabetes Complications Study. Diabetologia 2004;47:1266-1272
5. Tamborlane WV, Shervin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetics by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 1979;300:578
6. Ahern JH, Boland EA, Doanne R, Ahern JJ, Rose P, Vincent M, Tamborlane WV. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. Pediatr Diabetes 2002;3:10-15
7. Maniatis AK, Klingensmith GJ, Slover RH, Mowry CJ, Chase HP. Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics 2001;107:351-356
8. Weinzimmer SA, Swan KL, Sikes KA, Ahern JH. Emerging evidence for the use of insulin pump therapy in infants, toddlers, and preschool-aged children with type 1 diabetes. Pediatr Diabetes 2006;7(suppl 4):15-19
9. Fox LA, Buckloh LM, Smith SD, Wysocki T, Mauras N. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care 2005;28:177-1281
10. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy. A meta-analysis. Diabetes Care 2003;26:1079-1087
11. Glaser NS, Iden SB, Green-Burgeson D, Bennet C, Hood-Johnson K, Styne DM. Goodlin-Jones B. Benefits of an insulin dosage calculation device for adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2004;17:1533-1544
12. Wilson DM, Buckingham BA, Kunselman EL, Sullivan MM, Paguntalan HU, Gitelman SE. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care 2005;28:15-19
13. Bode BW, Steed RD, Davidsson PC. Reduction in severe hypoglycaemia with long term continuous subcutaneous insulin infusion in Type 1 diabetes. Diabetes Care 1996;19:324-327
14. Doyle EA, Weinzimmer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004;27:1554-1558
15. Hanaire-Broutin HH, Melki V, Bessieres-Lacombe S, Tauber J-P, the study group for the development of pump therapy in diabetes. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment. Diabetes Care 2000;23:1232-1235
16. Hoogma RPLM, Hammond PJ, Gomist R, Kerr D, Bruttomesso D, Bouter KP, Wiefels KJ, de la Calle H, Schweitzer DH, Pfohls M, Torlone E, Krinelke LG, Bolli GB on behalf on the 5 - nations study group. Diabet. Med 2006;23:141-147
17. Pickup J, Mattock M, Kerry S, Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes. A meta-analysis of randomised controlled trials. BMJ 2002;324:1-6
18. Retnakaran R, Hochman J, Hans De Vries J, Hanaire-Broutin H, Heine RJ, Melki V, Zinman B. Continuous subcutaneous insulin infusion versus multiple daily injections. Diabetes Care 2004;27:2590-2596
19. Ludvigsson J, Nordfeldt S. Hypoglycaemia during intensified insulin therapy of children and adolescents. J Pediatr Endocrinol Metabol 1998;11(Suppl 1):159-166
20. Bober E, Buyukgebiz A. Hypoglycemia and its effects on the brain in children with type 1 diabetes mellitus. Pediatr Endocrinol Rev 2005;2:378-382
21. Schoenle EJ, Shoenle D, Molinari L, Largo RH. Impaired intellectual development in children with type 1 diabetes: association with HbA1c, age at diagnosis and sex. Diabetologia 2002;45:108-114
22. Marreo DG, Guare JC, Vandagriff JL, Fineberg NS. Fear of hypoglycaemia in the parents of children and adolescents with diabetes: maladaptive or healthy response? Diabetes Educ 1997;23:281-286
23. Cryer PE. Hypoglycemia is the limiting factor in management of diabetes. Diabetes Metab Res Rev 1999;15:42-46
24. Ludvigsson J, Bolli GB. Intensive insulin treatment in diabetic children. Diabetes Nutr. Metabol 201;14:292-304
25. Teutsch SM, Herman WH, Dwyer DM, Lange JM. Mortality among diabetic patients using continuous subcutaneous insulin-infusion pumps. N Engl. J Med 1984;310:361 368
26. Steel J. Intrauterine death of baby because of incorrect pump use BMJ (Clin Res Ed) 1985;290:1787
27. Hanas R, Ludvigsson J. Hypoglycemia and ketoacidosis with insulin pump therapy in children and adolescents. Pediatr Diabetes 2006;7(Suppl 4):32-38
28. Knight G. Risks with continuous subcutaneous insulin infusion can be serious. BMJ 2001;323:693-694
29. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion: a new way to lower risk of severe hypoglycaemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999;22:1779-1784
30. Willi SM, Planton J, EgedeL, Schwarz S. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes. J Pediatr 2003;143:796-801
31. Hanas R, Adolfsson P. Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglcemia. Pediatr Diabetes 2006;7:25-31
32. Gough SCL. A review of human and analogue insulin trials. Diabetes Res Clin Pract 2006 (in press)
33. Higgens JPT, Green S, editors. Cochrane Handbook for Systemic Reviews of Interventions 4.26 (updated September 2006), http://www. cochrane.org/resources/ handbook/hbook.htm (accessed 6th October 2006)
34. Gardner MJ and Altman DG. Statistics with confidence confidence intervals and statistical guidelines. BMJ London 1989
35. Plotnick LP. Clark LM, Brancati FL, Erlinger T. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003;26:1142-1146
36. Nabhan ZM, Rardin L, Meier J, Eugster EA, DiMeglio LA. Predictors of glycemic control on insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Res Clin Pract 2006;74:217-221
37. Liberatore R, Perlman K, Buccino J, Artiles-Sisk A, Daneman D. Continuous subcutaneous insulin infusion pump treatment in children with type 1 diabetes mellitus. JPEM 2004;17:223-226
38. Mark-Fogg JE, Orlowski CC, Jospe N. Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective. Pediatr Diabetes 2005;6:17-21
39. Conrad SC, McGrath MT, Gitelman SE. Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus. J Pediatr 2002;140:235-240
40. Weinzimer SA, Ahern JH, Doyle EA, Vincent MR, Dziura J, Steffen AT, Tamborlane WV. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow up report. Pediatrics 2004;114:1601-1605
41. DiMeglio LA, Pottorf TM, Boyd SR, France L, Fineberg N, Eugster EA. A randomized controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 2004;145:380-384
42. Sulli N, Shashaj B. Long-term benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes: a 4 year follow-up. Diabet Med 2006;23:900-906
43. Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G, Lilos P, Dickerman Z, Phillip M. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomised open crossover trial. Pediatrics 2003;112:559-564
44. Cohen D, Weintrob N, Benzaquen H, Galatzer A, Fayman G, Phillip M. Continuous subcutaneous insulin infusion versus multiple daily injections an adolescents with type 1 diabetes mellitus: a randomized open crossover trial. JPEM 2003;16:1047-1050
45. Shehedeh N, Battelino T, Galatzer A, Naveh T, Hadash A, de Vries L, Phillip M. Insulin pump therapy for 1-6 year old children with type 1 diabetes. IMAJ 2004;6:284-286
46. Jeha GS, Karaviti LP, Anderson B, Smith O, Donaldson S, McGirk TS, Haymond MW. Insulin pump therapy in preschool children with type 1 diabetes mellitus improves glycemic control and decreases glucose excursions and the risk of hypoglycemia. Diabetes Technol Ther 2005;7:876-884
47. Litton J, Rice A, Friedman N, Oden J, Lee MM, Freemark M. J Pediatr 2002;141:490-495
48. Garg SK, Walker AJ, Hoff HK, D'Souza AO, Gottlieb PA, Chase HP. Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump. Diabetes Technol Ther 2004;6:9-15
49. Harmel AP, Mathur R. Similar A1C Outcomes in type 1 diabetic patients undergoing intensive diabetes management with preprandial rapid-acting insulin and either CSII or glargine. Diabetes care 2004;27:272-273
50. Hirsch IB, Bode BW, Garg S, Lane WS. Sussman A, Hu P, Santiago OM, Kolaczynski JW, for the insulin aspart CSII/MDI comparison study group. Diabetes Care 2005;28:533-538
51. Adana MR, Dominquez M, Machado A, Martin V, Gonzalez S. Esteva I, Anarte M, Soriguer F. Comparison of two programmes of intensive insulin therapy for type 1 diabetes: continuous subcutaneous insulin infusion (CSII) vs. insulin glargine. Diabet Med 2006;23(Suppl.4);337
52. Alemzadeh R, Ellis JN, Holzum MK, Parton EA, Wyatt DT. Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes. Pediatrics 2004;114:91-95
53. Bolli GB, Capani F, Home PD, Kerr D, Thomas R, Torlone E, Selam JL, Sola-Gazagnes A, Vitacolonna E. Comparison of a multiple daily injection regimen with once-daily insulin glargine basal insulin and mealtime lispro, to continuous subcutaneous insulin infusion: a randomised, open, parallel study. American Diabetes Association (ADA) Annual Meeting 2004. Abstract 455-P
54. Lepore G, Dodesini AR, Nosari I, Trevisan R. Effect of continuous subcutaneous insulin infusion vs multiple daily injection with glargine as basal insulin: an open parallel long-term study. Diabetes Nutr Metab 2004;17:84-89
55. Bode BW Steed R, Schleusener DS, Strange P. Switch to multiple daily injections with glargine and insulin lispro from continuous subcutaneous insulin infusion with insulin lispro: a randomized, open-label study using a continuous glucose monitoring system. Endocrine Practice 2005;11:157-164
56. Schiaffini R, Ciamalini P, Spera S, Cappa M, Crino A. An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetes. Diabetes Metab Res Rev 2005;21:347-352
57. Pickup JC, Kidd J, Burmiston S, Yemane N. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabetes Metab Res Rev 2006;22:232-237
58. Lepore G, Dodesini AR, Nosari I, Trevisan R. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as a basal insulin are equally better than traditional multiple daily insulin injection treatment. Diabetes care 2003;26:1321-1322
59. Danne T, Batelino T, Jarosz-Chobot P, the pedpump Study Group. The Pedpump Study: a low percentage of basal insulin and more than five daily boluses are associated with better centralized HbA1c in 1041 children on CSII from 17 countries. Diabetes 2005;(suppl 1):A453(Abstract)